Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 162,644 | 184,844 | 166,444 | 137,308 | 113,374 |
| Receivables | 62,536 | 47,031 | 66,223 | 72,809 | 61,538 |
| Inventories | 12,996 | 15,610 | 18,643 | 16,708 | 19,732 |
| TOTAL | $243,481 | $252,955 | $258,336 | $234,657 | $203,782 |
| Non-Current Assets | |||||
| PPE Net | 956 | 1,222 | 1,473 | 1,714 | 1,904 |
| Intangibles | 59,044 | 59,044 | 59,044 | 59,044 | 59,044 |
| Other Non-Current Assets | 59,039 | 63,344 | 45,299 | 50,180 | 45,455 |
| TOTAL | $119,039 | $123,610 | $105,816 | $110,938 | $106,403 |
| Total Assets | $362,520 | $376,565 | $364,152 | $345,595 | $310,185 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,495 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 8,386 | 21,185 | 10,087 | 11,554 | 12,658 |
| Accrued Expenses | 125,062 | 121,716 | 106,420 | 91,615 | 71,337 |
| Other current liabilities | 23,445 | 17,356 | 12,991 | 10,016 | 5,991 |
| TOTAL | $173,884 | $162,938 | $133,379 | $118,717 | $91,227 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,395 | 48,250 | 47,641 | 47,062 | 46,511 |
| Deferred Revenues | 4,496 | 2,681 | 3,881 | 5,532 | 1,241 |
| Other Non-Current Liabilities | 124,866 | 132,767 | 141,540 | 150,592 | 147,866 |
| TOTAL | $161,261 | $181,017 | $189,181 | $197,654 | $194,377 |
| Total Liabilities | $335,145 | $343,955 | $322,560 | $316,371 | $285,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 268,258 | 267,879 | 265,366 | 265,145 | 262,636 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,692,759 | -1,683,705 | -1,671,461 | -1,672,001 | -1,672,248 |
| Other shareholders' equity | 6 | 6 | 6 | 6 | 6 |
| TOTAL | $27,375 | $32,610 | $41,592 | $29,224 | $24,581 |
| Total Liabilities And Equity | $362,520 | $376,565 | $364,152 | $345,595 | $310,185 |